Suraksha Diagnostic Ltd
Tue 1/07/2025,12:19:36 | NSE : SURAKSHA
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 325.20
Previous Close
₹ 325.20
Volume
42891
Mkt Cap ( Rs. Cr)
₹1729.08
High
₹ 335.05
Low
₹ 325.20
52 Week High
₹ 449.00
52 Week Low
₹ 231.00
Book Value Per Share
₹ 38.25
Dividend Yield
0.00
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Suraksha Diagnostic Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
44%
Sell Order Quantity
56%
Bid Price
Qty
332.15
25
332.00
14
332.00
15
332.00
161
332.00
2
Bid Total
17978
Bid Price
Qty
332.85
27
333.00
30
333.00
38
333.00
600
334.00
9
Bid Total
22524
Option Chain
Analyzes market sentiment, predicts Suraksha Diagnostic Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Suraksha Diagnostic - Trading Window-XBRL
-
Suraksha Diagnostic - Trading Window
-
Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates
-
Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates
-
Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Suraksha Diagnostic - Investor Presentation
-
Suraksha Diagnostic - Copy of Newspaper Publication
-
Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Suraksha Diagnostic - Press Release
-
Suraksha Diagnostic - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Change in Management
-
Suraksha Diagnostic - Change in Auditors
-
Suraksha Diagnostic - Audited (Standalone And Consolidated) Financial Results Of The Company For The Quarter And Financial Ye
-
Suraksha Diagnostic - Outcome of Board Meeting
-
Suraksha Diagnostic - Outcome of Board Meeting
-
Suraksha Diagnostic Q4 net profit up 17.11% at Rs 8.01 cr
-
Suraksha Diagnostic - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Wednesday, 28 May 2025
-
Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates
-
Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Suraksha Diagnostic - Board Meeting Intimation
-
Suraksha Diagnostic - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Oblig
-
Suraksha Diagnostic - Update-Acquisition/Scheme/Sale/Disposal-XBRL
-
Suraksha Diagnostic - General Updates
-
Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Updates on Acquisition
-
Suraksha Diagnostic has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations
-
Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations
-
Suraksha Diagnostic - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Suraksha Diagnostic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Suraksha Diagnostic - Update-Acquisition/Scheme/Sale/Disposal-XBRL
-
Suraksha Diagnostic - General Updates
Key fundamentals
Evaluate the intrinsic value of Suraksha Diagnostic Ltd stock
Name | March-25 | March-24 | March-23 | March-22 | |
---|---|---|---|---|---|
Assets | 220.1374 | 189.5015 | 170.6301 | 169.0335 | |
Liabilities | 220.1374 | 189.5015 | 170.6301 | 169.0335 | |
Equity | 10.4162 | 6.9 | 6.9 | 6.9 | |
Gross Profit | 82.5903 | 71.1917 | 44.9867 | 47.5072 | |
Net Profit | 33.44 | 24.3839 | 7.189 | 23.751 | |
Cash From Operating Activities | 62.798 | 61.23 | 44.9253 | 42.3306 | |
NPM(%) | 13.42 | 11.15 | 3.78 | 10.64 | |
Revenue | 249.0954 | 218.5247 | 189.9854 | 223.1925 | |
Expenses | 166.5051 | 147.333 | 144.9987 | 175.6853 | |
ROE(%) | 16.78 | 12.24 | 3.6 | 11.92 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Suraksha Diagnostic Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 865.00 | 3.46 | 28.70 | 185.57 | 301.39 | 0.58 |
Lotus Eye Hospital and Institute Ltd | 71.16 | 0.00 | 203.31 | 676.19 | 3.55 | 0.00 |
Vaishali Pharma Ltd | 11.59 | -0.09 | 193.17 | 348.54 | 3.13 | 0.00 |
Astec Lifesciences Ltd | 937.75 | 1.42 | 0.00 | 637.59 | -687.10 | 0.00 |
Company Info
Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town
Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town
Read More
Parent Organisation
Suraksha Diagnostic Ltd.
Founded
15/03/2005
Managing Director
Ms.Ritu Mittal
NSE Symbol
SURAKSHAEQ
FAQ
The current price of Suraksha Diagnostic Ltd is ₹ 332.00.
The 52-week high for Suraksha Diagnostic Ltd is ₹ 335.05 and the 52-week low is ₹ 325.20.
The market capitalization of Suraksha Diagnostic Ltd is currently ₹ 1729.08. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Suraksha Diagnostic Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Suraksha Diagnostic Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Suraksha Diagnostic Ltd shares.
The CEO of Suraksha Diagnostic Ltd is Ms.Ritu Mittal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.